医学
重症监护医学
外科
梅德林
伤口闭合
疾病
组分(热力学)
计算机科学
风险分析(工程)
质量(理念)
作者
Somboonchokephisal,Techachan,Kaokai,Saokaew,Kanchanasurakit,Srisuwan
标识
DOI:10.33235/wpr.33.4.166-175
摘要
Background wound healing involves inflammation, proliferation and remodeling, with prolonged healing times posing significant challenges.Beta-glucans, natural polysaccharides, may enhance this process.Objective To evaluate the impact of beta-glucan on wound healing.Method A systematic review of MEDLINE, Embase, Scopus, and Cochrane Central databases was conducted.Eligible studies included randomised controlled trials, clinical trials, cohort, and case-control studies comparing beta-glucan to other treatments.Only English-language studies were included, with no time restrictions.Screening and assessment were independently performed by two reviewers using Rayyan.The risk of bias was evaluated using the ROB-2 tool and the Newcastle-Ottawa Scale (NOS).A meta-analysis was performed on the included studies.Result Beta-glucans promote immune cell activation and tissue repair, accelerating inflammation resolution.The metaanalysis of chronic wounds included two studies comprising a total of 354 participants, demonstrating a twofold increase in chronic wound healing rates at 12 weeks with the application of topical beta-glucan.In contrast, the analysis of acute wounds included two studies with a combined sample size of 290 participants.However, the findings for acute wounds were inconclusive.Conclusion Beta-glucan demonstrates potential as an adjunctive therapy for chronic wounds, significantly accelerating healing rates.Its clinical utility warrants further exploration.
科研通智能强力驱动
Strongly Powered by AbleSci AI